Development of a Novel Anti-caries Chewing Gum

NCT ID: NCT05946473

Last Updated: 2023-07-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-07-31

Study Completion Date

2024-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research study is designed to evaluate the chewing gum's ability to modulate the oral microbiome in human participants, in addition to its safety.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goal of this project is to develop a pre-biotic chewing gum that is designed to promote a healthy oral microbiome. The gum will contain compounds that will: a) be unable to be converted to acids; b) target the cariogenic S. mutans population; c) promote the stability of a healthy environment by modulating plaque pH via base-generating compounds; d) promote tooth remineralization by increasing saliva flow and by addition of calcium phosphate.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Plaque Dental Caries Periodontal Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental gum formulation

Participants will be asked to chew 2 pieces of chewing gum containing additives 2 times a day for a four-week period

Group Type EXPERIMENTAL

Gum base containing xylitol and essencial oils

Intervention Type DIETARY_SUPPLEMENT

Participants will be asked to chew 2 pieces of chewing gum containing additives for 10 minutes after eating in the morning, and after one meal in the evening, for a four-week period

Placebo

Participants will be asked to chew 2 pieces of pure gum base with no additives chewing gum 2 times a day for the same four-week period.

Group Type PLACEBO_COMPARATOR

Gum base with no additives

Intervention Type DIETARY_SUPPLEMENT

Participants will be asked to chew 2 pieces of pure gum base for 10 minutes after eating in the morning, and after one meal in the evening, for a four-week period

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Gum base containing xylitol and essencial oils

Participants will be asked to chew 2 pieces of chewing gum containing additives for 10 minutes after eating in the morning, and after one meal in the evening, for a four-week period

Intervention Type DIETARY_SUPPLEMENT

Gum base with no additives

Participants will be asked to chew 2 pieces of pure gum base for 10 minutes after eating in the morning, and after one meal in the evening, for a four-week period

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* In good general health, no relevant medical history
* No dental treatment in the previous 3 months
* Willing to participate and give written informed consent

Exclusion Criteria

* Patients undergoing fixed or removable orthodontic treatment
* Patients using removable prosthesis
* History of head and neck radiation therapy
* History of adverse reaction or allergies to xylitol or other additives
* Antibiotics use in the last four weeks
* Patients with any systemic diseases
* Xerostomia (also medication-induced)
* Smokers
* Currently using any mouth rinse
* Pregnant or breastfeeding women
Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Toronto

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dennis Cvitkovitch

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

44196

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of Xylitol on Oral Microbiota in Children
NCT01528969 COMPLETED PHASE1/PHASE2